The price of neratinib/neratinib revealed: How much does a box cost?

The launch of Neratinib is a major breakthrough in the treatment of breast cancer. This targeted therapy drug brings new hope to patients with hormone receptor-positive breast cancer who have received traditional therapies such as trastuzumab. And when it is combined with capecitabine, it shows great power in the battle against advanced breast cancer or that has spread to other parts of the body.

The original drug of neratinib in China has been successfully launched and has been included in Class B medical insurance, which undoubtedly brings good news to the majority of patients. However, it is worth noting that health insurance policies have limited coverage and only apply to patients who meet specific indications. For most patients, the price of neratinib remains an issue that cannot be ignored. In the market, the price of a box of 40mg*180 tablets of the original drug Neratinib is roughly around RMB 7,000. Although this price has been significantly reduced compared to the past, it is still a considerable expense for some families with limited financial conditions.

In comparison, the price of the original drug Neratinib in overseas markets is even more astonishingly high, possibly as high as more than 10,000 US dollars per box. This price difference not only reflects differences in healthcare systems in different countries, but also highlights the complexity of global drug prices. Fortunately, generic versions of neratinib also exist in overseas markets. Although these generic drugs differ from the original drugs in branding and packaging, their pharmaceutical ingredients are basically the same as the original drugs. Therefore, there is no significant difference in efficacy between generic drugs and original drugs. Taking neratinib produced by Bangladesh Yaopin International as an example, the price of a generic drug of 40mg*180 tablets is about more than 2,000 yuan (the price may fluctuate due to exchange rates). This price is significantly lower than the original drug, providing a more economical and affordable treatment option for the majority of patients.